---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-009007"
form_type: "8-K"
ticker: null
cik: "0001289047"
company_name: "AI Technology Group Inc."
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:53:37.655854+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AI Technology Group acquires AVM Biotechnology via share exchange; issues 100 common shares

## Summary
- Acquired 100% of AVM Biotechnology Inc. for 100 common shares of AI Technology Group.
- AVM becomes wholly-owned subsidiary; transaction intended as tax-free reorganization under Section 368.
- AVM has $1.125M convertible debentures outstanding, convertible into 584,800 common shares of the acquirer.
- Shares issued as restricted securities under Rule 144, exempt from registration under Section 4(a)(2).

## SEC filing metadata
- accession: 0001477932-25-009007
- form_type: 8-K
- cik: 0001289047
- company_name: AI Technology Group Inc.
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/aipg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-009007
- JSON: https://secwatch.observer/filing/0001477932-25-009007.json
- Plain text: https://secwatch.observer/filing/0001477932-25-009007.txt

## Source-grounded claims
- claim_id: f0667b3bd300af432e84c6ca8962daca10b40835
  claim: AI Technology Group Inc. completed an acquisition involving AVM Biotechnology Inc. for 100 common shares of the Corporation (closed 2025-12-15).
  evidence_excerpt: and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVM. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVM in exchange for 100 common shares of the Corporation . As a result, AVM became a wholly-owned subsidiary of the Corporation. The
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289047/000147793225009007/0001477932-25-009007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.